Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Dow
Queensland Health
US Army
McKinsey
QuintilesIMS
Federal Trade Commission
Baxter
Chubb

Generated: April 20, 2018

DrugPatentWatch Database Preview

Polidocanol - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for polidocanol and what is the scope of polidocanol freedom to operate?

Polidocanol
is the generic ingredient in two branded drugs marketed by Chemisch Fbrk Krsslr and Provensis, and is included in two NDAs. There are fourteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Polidocanol has one hundred and eighty-five patent family members in thirty-nine countries.

Two suppliers are listed for this compound.
Summary for polidocanol
Pharmacology for polidocanol
Drug ClassSclerosing Agent
Mechanism of ActionSclerosing Activity
Physiological EffectVascular Sclerosing Activity
Synonyms for polidocanol
2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol
3,6,9,12,15,18,21,24,27-Nonaoxanonatriacontan-1-ol
3055-99-0
9043-30-5
AC1LCVC1
AEO-9
Aethoxy-sklerol
AKOS028108701
AN-6543
API0005051
C12E9
C13493
CAS-3055-99-0
CHEBI:46859
CHEMBL1231723
CTK1C2495
D05ZPL
DB06811
Detergent Screening Solution 23/Fluka kit no 66317
DODECYL NONA ETHYLENE GLYCOL ETHER
Dodecyl nonaethylene glycol ether
Dodecylnonaglycol
Dodecylnonaoxyethylene glycol monoether
DSSTox_CID_19721
DSSTox_GSID_39721
DSSTox_RID_79436
DTXSID5039721
EINECS 221-284-4
genapol X 080
genapol X-080
Genapol X080
GK9185
J-018016
KS-00000Y0K
laureth-9
LP016773
Macrogol 9 lauryl ether
MFCD00043375
MFCD00163738
MolPort-003-935-762
NCGC00166290-01
NCGC00166290-02
NCGC00166290-03
Nonaethylene glycol monododecyl ether
Nonaethylene glycol monododecyl ether, nonionic surfactant
nonaethylene glycol monolauryl ether
Nonaethyleneglycol monododecyl ether 1 mM solution
Nonaethyleneglycol monododecyl ether solution
NONAETHYLENEGLYCOLMONODODECYLETHER
Oligoethylene glycol monoalkyl ether
ONJQDTZCDSESIW-UHFFFAOYSA-N
PEG-9 lauryl ether
POELE
Poly(oxy-1,2-ethanediyl),a-isotridecyl-w-hydroxy-
Polydocanol
Polyethylene glycol 450 lauryl ether
Polyethylene glycol monoalkyl ether
Polyethylene glycol monoisotridecyl ether
Polyoxyethylen-9-laurylether
Polyoxyethylene (9) lauryl ether
Polyoxyethylene 9 lauryl ether
Polyoxyl 9 lauryl ether
SCHEMBL25580
SR-01000944476
SR-01000944476-1
Tox21_112394
Tox21_112394_1
ZINC8214662

US Patents and Regulatory Information for polidocanol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Provensis VARITHENA polidocanol SOLUTION;INTRAVENOUS 205098-001 Nov 25, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Provensis VARITHENA polidocanol SOLUTION;INTRAVENOUS 205098-001 Nov 25, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Provensis VARITHENA polidocanol SOLUTION;INTRAVENOUS 205098-001 Nov 25, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Chemisch Fbrk Krsslr ASCLERA polidocanol SOLUTION;INTRAVENOUS 021201-001 Mar 30, 2010 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for polidocanol

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,763,269 Therapeutic foam ➤ Sign Up
8,091,801 Generation of therapeutic microfoam ➤ Sign Up
8,048,439 Therapeutic foam ➤ Sign Up
9,545,378 Aerosol valve ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Daiichi Sankyo
Chubb
Accenture
McKinsey
Medtronic
Dow
Farmers Insurance
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.